Close
Planning and Development Division
Challenge to new field
“Challenging Sprit”
- HOME >
- Businesses and Products >
- Planning and Development Division >
- Life Sciene Field
Life Sciene Field
Nissan Chemical Corporation has combined its unparalleled expertise in materials and biological evaluation to develop game-changing innovations. Our solutions benefit drug discovery including oligonucleotide therapeutics, material development for regenerative medicine and other healthcare business.
- Oligonucleotide Drug Discovery Platform
-
Nissan Chemical’s oligonucleotide drug discovery platform, consisting of (1) modified nucleic acid MCEs, (2) single-stranded herteroduplex oligonucleotides, and (3) in silico sequence design algorithms, provides antisense oligonucleotide therapeutics with high efficacy and safety.
We are working on innovative oligonucleotide drug discovery using our own platform through in-house research and collaborations with pharmaceutical companies to build our R&D portfolio.
- Cell culture material - FCeM® -
-
The 3-dimensional (3D) culture method "FCeM(TM) series" realizes suspension and dispersion culture of adherent cells, and provides a culture environment that reduces stress and damage to cells during culture. FCeM(TM) Advance therein makes non-freeze storage and transport of spheroids and organoids possible, while Cellhesion(TM)is a new culture scaffold that enables distributed culture of somatic cells showing anchorage-dependent proliferation such as mesenchymal stem cells.
- Anti-adhesion Coating Materials prevelex®
-
prevelex® is hydrophilic, anti-adhesion coatings that are applicable to regenerative medicine. prevelex® improves spheroid formation, bioanalysis, and drug screening due to its high anti-adhesion efficacy against cells, proteins including antibodies, nucleic acids, and viruses.
Concept movie (YouTube)
- Cell Attachment/Detachment Materials
-
prevelex-CAT® represents a novel concept in spheroid production technology. It offers highly precise size control and excellent scalability, enabling seamless automation and large-scale manufacturing.
Cegnet™ have been developed for suspension cells, such as CAR-T cells. This technology is expected to support automated manufacturing for ex vivo gene therapies and to enhance viral transduction efficiency.
Contact Us
Handling division
- Healthcare Business Development Department
